Stock Events

Acadia Pharmaceuticals (ACAD.MX) Q3 2018 Earnings

8AugConfirmed
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-11.87
-10.68
-9.49
-8.3

Details

Expected EPS
-8.303535
Actual EPS
-9.410673000000001
Surprise EPS
-1.11
Surprise Percent
+13.33%

Description

Acadia Pharmaceuticals (ACAD.MX) has reported earnings of -9.410673000000001 per share for Q3 2018.

0 Comments

Share your thoughts